Clinical Trials

153 enrolled

Burkitt Lymphoma, Leukemia, Biphenotypic, Acute

NCT06890884 2026-03-13

MK-2140-011

594 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT05800366 2026-03-05

A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma

41 enrolled

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT03755804 2026-02-23

Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17

232 enrolled

Hodgkin Disease, Neoplasms

NCT03407144 2026-02-19

MK-3475-667

340 enrolled

Hodgkin Disease

NCT06692452 2026-01-07

Tazemetostat Plus CHOP in 1L T-cell Lymphoma

Phase 2 Suspended

24 enrolled

Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, T-Cell, Peripheral, Enteropathy-Associated T-Cell Lymphoma

NCT05761171 2025-12-22

A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia

78 enrolled

Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04479267 2025-09-29

Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Previously Untreated Lymphoma

8 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT04546620 2025-08-06

REMoDL-A

453 enrolled

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT02828358 2025-02-27

Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement

78 enrolled 15 charts

Burkitt Lymphoma, Leukemia, Biphenotypic, Acute

NCT05406401 2024-10-15

waveLINE-007

60 enrolled

Lymphoma

NCT03899337 2023-01-09

STELLAR

105 enrolled

Lymphoma, Non-Hodgkin, Leukemia, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT01451515 2022-06-28

NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma

23 enrolled 14 charts

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03465527 2022-04-01

Pre-phase Treatment Before R-CHOP Chemotherapy in Elderly Patients With Newly Diagnosed DLBCL

37 enrolled

Phase 2 Not yet recruiting

Lymphoma, Large B-Cell, Diffuse

NCT05280626 2022-03-15

First-line Treatment of P53 Mutation With PD-L1 Expression in DLBCL With Anti-PD-1 Mab and R-CHOP

100 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT00637832 2022-01-06

Rituximab, Combination Chemotherapy, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed Follicular Non-Hodgkin Lymphoma

Phase 2 Terminated

1 enrolled

Lymphoma, Lymphoma, Follicular

NCT01427114 2021-05-06

R-CVP for the Treatment of Non-conjunctival Ocular Adnexal MALT Lymphoma (OAML)

33 enrolled

Lymphoma

NCT02890602 2020-02-20

Erythropoietin for Management of Anemia Caused by Chemotherapy

53 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT01719835 2018-03-15

CHEMO-T

87 enrolled

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Lymphoma, Large-Cell, Anaplastic, Enteropathy-Associated T-Cell Lymphoma

NCT00079105 2017-03-30

A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years

175 enrolled

Hodgkin Disease, Lymphoma

NCT00666484 2014-12-04

Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma

47 enrolled

Hodgkin Disease, Lymphoma, Neurotoxicity Syndromes

NCT00971763 2014-12-04

Gemcitabine Hydrochloride, Cyclophosphamide, Vincristine Sulfate, Prednisolone, and Rituximab in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma

62 enrolled

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT00513955 2014-11-05

Combination Chemotherapy With or Without Bortezomib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

50 enrolled

Lymphoma, Lymphoma, Mantle-Cell

NCT01068392 2014-11-04

Oxaliplatin and Prednisolone (Ox-P) for Patients With Relapsed or Refractory Marginal Zone B-cell Lymphoma(MZL)

42 enrolled

Recurrence, Lymphoma, B-Cell, Lymphoma, B-Cell, Marginal Zone

NCT00494780 2014-07-11

MUNIN

59 enrolled 21 charts

Lymphoma, Follicular

NCT01005758 2014-01-10

Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

180 enrolled

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00575406 2013-08-30

NHL-14

94 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT00669812 2013-08-26

High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma

60 enrolled

Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT00002532 2013-08-07

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00025064 2013-08-07

Combination Chemotherapy With or Without Radiation Therapy and Peripheral Stem Cell Transplant in Treating Children With Hodgkin's Lymphoma

260 enrolled

Lymphoma, Recurrence

NCT00130195 2008-11-14

Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL)

100 enrolled